Sulfanilamide

Sulfanilamide

SCHEMBL7766519

CCO.Nc1ccc(S(N)(=O)=O)cc1.c1ccc2ccccc2c1

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

folP

The experimentally established mechanism targets of Sulfanilamide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 17/20 0.61
CA9 Q16790 15/20 0.61
CA1 P00915 14/20 0.61
CA12 O43570 12/20 0.61
CA14 Q9ULX7 6/20 0.61
CA7 P43166 5/20 0.61
CA4 P22748 4/20 0.61
CA6 P23280 4/20 0.61
CA5A P35218 4/20 0.61
CA5B Q9Y2D0 4/20 0.61
CA13 Q8N1Q1 2/20 0.61
USP2 O75604 1/20 0.61
TSHR P16473 1/20 0.61
TDP1 Q9NUW8 1/20 0.61
AGO2 Q9UKV8 1/20 0.61
LMNA P02545 1/20 0.52
GAA P10253 1/20 0.48
CA3 P07451 1/20 0.47
PLA2G7 Q13093 1/20 0.47
HTT P42858 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Sulfanilamide SCHEMBL419065 0.91 CA2 (0.74) CA2CA9CA1CA12CA14
Sulfanilamide SCHEMBL27483941 0.89 CA2 (0.77) CA2CA9CA1CA12CA14
Sulfanilamide SCHEMBL629179 0.81 CA2 (0.77) CA2CA9CA1CA12CA14
Sulfanilamide SCHEMBL2215151 0.81 CA2 (0.77) CA2CA9CA1CA12CA14
Sulfanilamide SCHEMBL28201481 0.80 CA2 (0.85) CA2CA9CA1CA12CA14
Sulfanilamide SCHEMBL28069325 0.79 CA2 (0.69) CA2CA9CA1CA12CA14
Sulfanilamide SCHEMBL8380125 0.78 CA2 (0.81) CA2CA9CA1CA12CA14
Sulfanilamide SCHEMBL27911829 0.78 CA2 (0.81) CA2CA9CA1CA12CA14
Sulfanilamide SCHEMBL8449748 0.78 CA2 (0.90) CA2CA9CA1CA12CA14
Sulfanilamide SCHEMBL4188099 0.78 CA2 (0.90) CA2CA9CA1CA12CA14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1115705-A1 NOVEL COMPOUNDS AstraZeneca AB (SE) 2001-07-18 EP disclosed
WO-2000018736-A1 NOVEL COMPOUNDS ASTRAZENECA AB (SE) 2000-04-06 WO disclosed